Cervical Cancer – New drug combination: Balstilimab Plus Zalifrelimab
Overview Advanced cases of cervical cancer pose a challenge for physicians to treat. Once the cancer cells have spread to other tissues, procedures such as
Lung cancer – Tiragolumab Plus Atezolizumab Survival
Overview Lung cancer is a very challenging condition to manage, especially when discovered late. The incredibly high incidence of lung cancer – mostly caused by
Breast Cancer – NERLYNX for Leptomeningeal Metastases
Overview The spread of cancer cells beyond the original site of the tumor is a very challenging process. When cancer cells of the breast are
Glioblastoma – A New Combination Treatment You Need to Know
Overview Glioblastoma, or GBM, is an aggressive type of tumor that occurs in the brain. Due to the location of this tumor and the limited
Cholangiocarcinoma and Gallbladder Cancer – Breakthrough with Imfinzi
Overview Ever since their discovery, advanced cases of cholangiocarcinoma and gallbladder cancers have been a big issue for doctors to manage. Since these cancers only
Rechallenge Treatment for Metastatic Colorectal Cancer Patients
Overview Over the past few years, researchers have been trying to find new treatment protocols for colorectal cancer by combining anticancer drugs. Fortunately, these efforts
Melanoma – Alrizomadlin, Fast Track Designation for Advanced Disease
Overview The FDA has granted a Fast Track Designation to the novel MDM2-p53 inhibitor named “Alrizomadlin” (APG-115) for the treatment of patients with unresectable or
Glioblastoma – Berubicin for the Treatment of Recurrent Disease
Overview Based on its potential to prolong overall survival in patients with Glioblastoma, GBM, Berubicin was granted Fast Track Designation by the American Food and
Cervical Cancer – Accelerated Approval to Tivdak
About the FDA decision in Cervical Cancer The Food and Drug Administration, the FDA, has granted an accelerated approval to Tivdak (Tisotumab Vedotin-tftv) for the
Nasopharyngeal Carcinoma – Toripalimab, A New Breakthrough Drug
Overview Nasopharyngeal carcinoma is a malignant tumor that affects the head and neck. Typically, this cancer starts in the upper part of the throat and
“Significant improvement. Now no evidence of active malignancy”
He is our client, a charming 58 year old man and has colorectal cancer with liver metastases. He received the standard protocol until he reached
Melanoma – UV1 plus Keytruda, A Breakthrough
Overview Melanoma is a unique type of skin cancer that originates from cells known as melanocytes. The main function of these cells is to produce
